Hepatic Fat Reduction Due to Resmetirom in Patients With Nonalcoholic Steatohepatitis Is Associated With Improvement of Quality of Life
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatic Fat Reduction Due to Resmetirom in Patients With Nonalcoholic Steatohepatitis Is Associated With Improvement of Quality of Life
Authors
Keywords
Thyroid Hormone Receptor-β, Patient-Reported Outcome, Quality Of Life
Journal
Clinical Gastroenterology and Hepatology
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-07-28
DOI
10.1016/j.cgh.2021.07.039
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the Medicare population
- (2020) Mehmet Sayiner et al. Hepatology International
- AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review
- (2020) Zobair M. Younossi et al. GASTROENTEROLOGY
- Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life
- (2019) Zobair M. Younossi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2019) Stephen A Harrison et al. LANCET
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis
- (2017) Christina N Katsagoni et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: A prospective cohort study
- (2016) Elliot B. Tapper et al. HEPATOLOGY
- Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice
- (2016) Giulio Marchesini et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review
- (2016) Pegah Golabi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Depression in Patients with Nonalcoholic Fatty Liver Disease and Chronic Viral Hepatitis B and C
- (2011) Ali A. Weinstein et al. PSYCHOSOMATICS
- Quality of life in adults with nonalcoholic fatty liver disease: Baseline data from the nonalcoholic steatohepatitis clinical research network
- (2009) Kristin David et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search